"Stem Cell Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The transfer of STEM CELLS from one individual to another within the same species (TRANSPLANTATION, HOMOLOGOUS) or between species (XENOTRANSPLANTATION), or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). The source and location of the stem cells determines their potency or pluripotency to differentiate into various cell types.
| Descriptor ID |
D033581
|
| MeSH Number(s) |
E02.095.147.500.500 E04.936.225.687
|
| Concept/Terms |
Stem Cell Transplantation- Stem Cell Transplantation
- Stem Cell Transplantations
- Transplantations, Stem Cell
- Transplantation, Stem Cell
|
Below are MeSH descriptors whose meaning is more general than "Stem Cell Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Stem Cell Transplantation".
This graph shows the total number of publications written about "Stem Cell Transplantation" by people in this website by year, and whether "Stem Cell Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
| 2016 | 0 | 3 | 3 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Stem Cell Transplantation" by people in Profiles.
-
Comparative RNAi Screens in Isogenic Human Stem Cells Reveal SMARCA4 as a Differential Regulator. Stem Cell Reports. 2019 05 14; 12(5):1084-1098.
-
Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas. J Clin Oncol. 2016 11 20; 34(33):4015-4022.
-
Cytokine Release Patterns in Mixed Lymphocyte Culture (MLC) of T-Cells with Dendritic Cells (DC) Generated from AML Blasts Contribute to Predict anti-Leukaemic T-Cell Reactions and Patients' Response to Immunotherapy. Cell Commun Adhes. 2015 Apr - Dec; 22(2-6):49-65.
-
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor. Stem Cell Reports. 2016 Apr 12; 6(4):539-551.
-
Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignancies. Br J Haematol. 2015 Apr; 169(1):90-102.
-
A modular gain-of-function approach to generate cortical interneuron subtypes from ES cells. Neuron. 2013 Dec 04; 80(5):1145-58.
-
CD4(+)and CD8(+)T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT. Immunobiology. 2014 Apr; 219(4):247-60.
-
Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of German trials. Pediatr Blood Cancer. 2011 Apr; 56(4):578-83.
-
Where do the leukaemia relapses come from? J Mol Med (Berl). 2010 Mar; 88(3):219-22.
-
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. J Clin Oncol. 2009 Jan 20; 27(3):377-84.
MeSH information
